Weight Change and Predictors of Weight Change Among Patients Initiated on Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide or Bictegravir/Emtricitabine/Tenofovir Alafenamide: A Real-World Retrospective Study.

Emond, Bruno; Rossi, Carmine; Côté-Sergent, Aurélie; Dunn, Keith; Lefebvre, Patrick; Lafeuille, Marie-Hélène; Donga, Prina

Emond, Bruno; Rossi, Carmine; Côté-Sergent, Aurélie; Dunn, Keith; Lefebvre, Patrick; Lafeuille, Marie-Hélène; Donga, Prina.

Afiliación

Emond B; Analysis Group, Inc.
Rossi C; Analysis Group, Inc.
Côté-Sergent A; Analysis Group, Inc.
Dunn K; Janssen Scientific Affairs, LLC.
Lefebvre P; Analysis Group, Inc.
Lafeuille MH; Analysis Group, Inc.
Donga P; Janssen Scientific Affairs, LLC.

J Health Econ Outcomes Res ; 8(1): 88-98, 2021 Jun 14.

Article en En | MEDLINE | ID: mdl-34179212

Palabras clave

body mass index; electronic health records; hiv; integrase inhibitors; observational study; protease inhibitors; weight gain

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: J Health Econ Outcomes Res Año: 2021 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google